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SUMMARY
Recent progress revealed the complexity of RNA
processing and its association to human disorders.
Here, we unveil a new facet of this complexity. Com-
plete loss of function of the ubiquitous splicing factor
SFPQ affects zebrafish motoneuron differentiation
cell autonomously. In addition to its nuclear localiza-
tion, the protein unexpectedly localizes to motor
axons. The cytosolic version of SFPQ abolishes mo-
tor axonal defects, rescuing key transcripts, and re-
stores motility in the paralyzed sfpq null mutants,
indicating a non-nuclear processing role in motor
axons. Novel variants affecting the conserved
coiled-coil domain, so far exclusively found in fALS
exomes, specifically affect the ability of SFPQ to
localize in axons. They broadly rescue morphology
and motility in the zebrafish mutant, but alter motor
axon morphology, demonstrating functional require-
ment for axonal SFPQ. Altogether, we uncover the
axonal function of the splicing factor SFPQ in motor
development and highlight the importance of the
coiled-coil domain in this process.
INTRODUCTION
Post-transcriptional regulation of gene expression plays a funda-
mental role in the temporal and spatial modulation of develop-
ment and has been recently found at the core of many disease
mechanisms. In recent years, much progress has been made
in unraveling the players in this process, revealing a daunting
complexity in the mechanisms of RNA processing and transport.
This complexity is not only created by the many players involved
and their intricate interactions in multiple aspects of RNA regula-
tion (transcription termination, non-coding RNA interaction, RNA
processing, and transport), but is also generated by the complex
role of long non-coding RNAs (Derrien et al., 2012; Mercer and
Mattick, 2013; Okazaki et al., 2002).
Our zebrafish forward-genetic screen for embryos displaying
abnormalities in neural development led to the isolation of a
null mutation in the gene encoding splicing factor proline/gluta-
mine-rich (SFPQ, a.k.a. PSF). SFPQ is a multifunctional protein
(Shav-Tal and Zipori, 2002), known to be involved in pre-mRNA
splicing (Rosonina et al., 2005), transcriptional repression, and
DNA repair, originally isolated from the spliceosome. It is associ-
ated with nuclear paraspeckles (Fox et al., 2002) involved in nu-
clear retention of defective RNAs into subnuclear sequestration
of SFPQ complexes (Barry et al., 2014; Johnson, 2012) and
with small cytoplasmic RNA granules, the function of which is
not yet understood (Kanai et al., 2004).
The structure of SFPQ is conserved and closely related to
NONO and PSPC1 proteins, with which it forms heterodimers.
They all contain tandem RNA recognition motif domains, a
family-specific NOPS (Nono, Pspc1, and Sfpq) domain and a
coiled-coil region (Passon et al., 2012). SFPQ additionally con-
tains a DNA-binding domain (DBD) and an N-terminal proline/
glutamine-rich low-complexity region (Lee et al., 2015; Patton
et al., 1993; Peng et al., 2002; Shav-Tal and Zipori, 2002; Urban
et al., 2000). Its RNA-binding activity has been implicated in a
variety of cellular processes (Chanas-Sacre´ et al., 1999; Fig-
ueroa et al., 2009; Lukong et al., 2009; Rosonina et al., 2005;
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Shav-Tal et al., 2001; Shav-Tal and Zipori, 2002; Sutherland
et al., 2005). Of interest for our study, SFPQ has recently been
shown to regulate signal-induced alternative splicing (Ray
et al., 2011) and to be required, directly or indirectly, for transport
of an RNA regulon that promotes sensory axon viability (Cosker
et al., 2016). SFPQ is present in cytoplasmic aggregates in brains
of patients with a variety of neurodegenerative disorders and is
mis-regulated in autism and dyslexia (Chang et al., 2015; Ke
et al., 2012; Kubota et al., 2010; Stamova et al., 2013; Tapia-
Pa´ez et al., 2008). The humanSFPQ gene lies in a region on chro-
mosome 1p34-p36 linked to speech disorders and language
impairment (Grigorenko et al., 2001; Kubota et al., 2010; Misci-
marra et al., 2007; Rabin et al., 1993; Tzenova et al., 2004).
Phenotypic characterization of our zebrafish sfpq homozy-
gous mutants revealed a restricted set of defects, unexpected
for a ubiquitously expressed multifunctional protein. The CNS
was prominently affected, showing brain boundary and axonal
defects associated with absence of motility. We assessed the
specificity of SFPQ functional targets by microarray RNA
profiling analysis, comparing the transcriptome of the sfpq ho-
mozygous mutants to its wild-type and heterozygous siblings at
the earliest stage at which the phenotype is robustly recogniz-
able. An unexpectedly narrow set of transcripts was affected
by the loss of SFPQ, with a specific enrichment in alternatively
spliced neuronal and synaptic transcripts. The use of a tagged
version of the protein revealed that SFPQ is abundant in the
axons of a subset of neuronal populations including all motor
neurons (MNs), an observation confirmed by antibody staining
of endogenous SFPQ. We demonstrated that these axons also
contain intron-retaining transcripts and spliceosome core com-
ponents, suggesting a possible involvement in non-canonical
cytoplasmic RNA processing. We demonstrate that cyto-
plasmic SFPQ is functionally relevant to MN differentiation,
showing that a non-nuclear version of the protein is able to
restore a specific set of neuronal transcripts and rescue the
axonal and motility defects in the zebrafish null mutant. The se-
vere motor phenotype of the zebrafish null mutant and pres-
ence of SFPQ in aggregates in human degenerative disorders
encouraged us to screen ALS patients for SFPQ mutations.
From these patients, we identified two novel SFPQ missense
variants affecting the coiled-coil domain of the protein and ab-
sent from 66,000 normal human exomes. In double-blinded
zebrafish null mutant rescue experiments, the ALS-linked
SFPQ variants uniquely led to motor axon morphological ab-
normalities in the rescued mutants and showed a much-
reduced cytoplasmic localization. These findings uncover the
importance of the non-nuclear axonal function of SFPQ protein
in motor development and indicate the importance of the
coiled-coil domain in this process.
RESULTS
Loss of Zebrafish sfpq Affects Development of Brain
Boundaries and Motor Function
A recessive zebrafishmutant identified during a small-scale ENU
mutagenesis screen was selected for its early brain boundary
defects and was named coma due to its vegetative state and
its later comma-shaped body (Figure S1A). Preceding any
morphologically visible defect, homozygous mutants fail to
twitch their tail at 15–16 somite stage (ss). By 24 hr post-fertiliza-
tion (hpf), all homozygous mutant larvae fail to undergo the
morphogenetic changes required to form the posterior mesen-
cephalic wall and a mature isthmic organizer (Figures 1A and
1B), and 22% have asymmetric ectopic mesencephalic neuroe-
pithelial folds (Figures 1C and 1D). The expression of midbrain-
hindbrain boundary (MHB) markers, pax2.1 and fgf8, is normal
at early stages, but reduced or lost at later stages, indicating
that the midhindbrain boundary is established, but not main-
tained (Figures 1E, 1F, and S1B). The mutant also lacks rhombo-
mere boundaries, failing to express early boundarymarkers such
as rfng (Figures 1G and 1H), and undergoes ectopic neurogene-
sis in boundary regions (Figures 1I–1L). These boundary defects
are neither due to a general loss of apical-basal polarity, nor to
specific cell death in these areas (Figures S2E and S2H).
Most other aspects of CNS patterning appear normal in the
mutant apart from a loss of Wnt signaling activity observed in
the hypothalamus (Figure S1D). No significant difference in cell
proliferation was found during the two first days of development
(Figures S2A–S2F and S2I). All mutant embryos develop further
defects such as lack of heart looping, pericardial edema, short
curved body, and kinky tail (Figure S1A); never acquire motility
(Movie S1); and die by 4 days post-fertilization (dpf).
The genetic characterization of coma/ by fine mapping and
candidate gene analysis indicated that the genetic lesion was in
sfpq. This was confirmed by complementation test with an
existing allele of the gene (whitesnake, wistr241) (Lowery et al.,
2007). The point mutation in coma was then identified by
sequencing as a C-to-T transition at +604 position from the
ATG start codon, changing CAA to TAA (glutamine [Q] at aa.
203 to STOP codon) in the proline (P)/glutamine (Q)-rich domain
of the protein (Figure 1M). The rescue of the mutant phenotype
by microinjection of the zebrafish or human sfpq full-length
mRNA (Figures S1C and 7) establishes that coma is a novel
null allele of the gene sfpq (named sfpqkg41) located at 56.2 cM
on zebrafish chromosome 19 and that the protein has a
conserved function in zebrafish and human.
Sfpq Is Cell-Autonomously Required for Motor Axon
Development
As the earliest observable sfpqkg41 defect is its lack of early
motility at 16 ss, we investigated its neuronal differentiation.
From 24 hpf onward, homozygous sfpq/ embryos show
defects in axonal tracts in discrete areas of CNS and peripheral
nervous system (PNS), with lack of posterior and supra-optic
commissures and reduced inter-rhombomeric commissural
axons (Figures 2A–2D). These also show defects in the axonal
projections of both cranial (Figures 2E and 2F) and spinal cord
MNs (Figures 2G–2P).
The sfpqkg41 anterior spinal motor axons do occasionally
manage to form and exit normally the spinal cord, neuronal
behavior more readily observed in the Tg(Xla.Tubb2b:Hsa.
MAPT-GFP)zc1 background, expressing a GFP-tagged microtu-
bule-associated Tau protein in neurons, indicating that Tau over-
expression has some beneficial effect in sfpqkg41 neurons. In this
transgenic background, around 15% of homozygous mutants
form anterior axons with neuro-muscular junctions (NMJs) and
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can generate some movements (Movie S2). In all other back-
grounds, most anterior MNs do not progress, stalling at the hori-
zontal myoseptum and either stop there or branch excessively
with poor progression along the somitic mass (Figures 2G–2N).
Immunostaining with a-bungarotoxin (a-btxn; data not shown)
and pre-synaptic SV2 shows normal pre- and post-synaptic
pre-patterning in themutant (Figures 2O and 2P; data not shown).
However, the mutants never form mature NMJs. The motor axon
defect of the mutant is not due to cell death, as healthy MN cell
bodies are found until day 4 (GFP+ in Figures 2G–2N) and themu-
tants lacking p53 (thereby devoid of cell death; Sakhi et al., 1994)
still exhibit severe axogenesis defects (Figures S2J–S2Q).
Somitic muscle differentiation occurs normally in the sfpq
mutant, with typical V-shaped somitic boundaries, proper differ-
entiation of both slow and fast muscle, and formation of sarco-
meres (Figures S2R–S2Y). The absence of axons in the vast
majority of MNs, without initial defects in muscle differentiation,
indicates that the primary defect is in the MNs.
Mosaic experiments (Figure 3) further demonstrate that sfpq
is cell-autonomously required in neurons for their maturation.
Figure 1. SFPQ Is Required for Brain Boundaries
Dorsal (A–D and I–L) and lateral (E–H) views of 32 hpf zebrafish brain with anterior to the top (A and B) or left (C–L).
(A and B) Immunostaining of sfpq; Tg(dlx4.6 GFP) embryos. Anti-acetylated tubulin staining (red) reveals asymmetrical folds in the midbrain (white arrowheads)
and thickening of the isthmic organizer (IsO) in coma mutant (B; n = 8) compared to its wild-type sibling (A; n = 24). GFP staining (green) reveals disorganized
neuronal distribution in the cerebellum.
(C and D) Dorsal views, anterior to the top, of sibling (C) and mutant (D) sfpq;Tg(bactin: HRAS gfp) embryos showing failure of morphological thinning of the
isthmus (white arrows in D, n = 9/9) in the homozygous mutant.
(E and F) Expression of pax2.1 in the MHB, greatly reduced in all sfpq mutants (F; n = 10) compared to siblings (E; n = 30) at 36 hpf.
(G and H) Expression of boundary marker, rfng, in siblings (G; n = 21) and mutant (H; n = 7, reduced or absent) at 24 ss.
(I and J) Expression of zash1a in the hindbrain at 15 ss, in siblings (I; n = 19) and mutant (J; n = 6).
(K and L) HuC staining at 32 hpf, in siblings (K; n = 17) and mutant (L; n = 5). Scale bar, 100 mm.
(M) Schematic of the sfpq gene and the zebrafish and human mutations described in this report and, below, the sequence altered in the zebrafish comamutant.
PQ, proline (P) glutamine (Q) rich; RRM, RNA recognition motif; NOPS, NONA/paraspeckle domain; NLS, nuclear localization signals.
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Cell transplantations in spinal cord territory of the neural plate
at 70% epiboly show that sfpq/ MNs transplanted into
wild-type embryos fail to show motor axon projections in 30
hpf host embryos (Figures 3G–3L and 3N; n = 8). Transplanted
Figure 2. Axonogenesis Is Affected in
sfpq–/– Embryos
Lateral (A, B, and G–P) and dorsal (C–F) views,
anterior to the left, of zebrafish brain at 32 hpf (A
and B) and spinal cord at 24–56 hpf.
(A and B) sfpq;Tg(dlx4.6:gfp) embryos. Lack of
supra-optic commissure (white arrow) and poste-
rior commissure (white arrowhead) in coma (n = 8/
32) is revealed by acetylated tubulin staining.
(C and D) Dorsal view, anterior to the left of acet-
ylated tubulin staining showing hindbrain disor-
ganized axonal tracks in sfpq mutant (D; green
arrowhead, n = 8) compared to siblings (C; n = 26).
(E and F) Dorsal view, anterior to the left of GFP+
motor neurons in sfpq; Tg(isl1:gfp) siblings (E) and
mutant (F), showing cranial motor neuronal clus-
ters lacking axonal projections in the mutant (red
arrowhead, n = 7).
(G–N) Lateral view, anterior to the left, of confocal
live imaging, showing temporal defect in axono-
genesis in the majority of spinal motor neurons in a
mutant (H, J, L, and N; n = 14) compared to a
sibling (G, I, K, and M; n = 42) in the Tg(mnx1: gfp)
background.
(O and P) Lateral view, anterior to the left, of SV2
antibody staining of siblings (O) and sfpq null
mutant (P), showing pre-synaptic protein in the
few axons formed in sfpq mutants (n = 9). Scale
bar, 100 mm.
sfpq/ ventral neuro-progenitors do
not show significant change in motor
to interneuron ratio (Figure 3M; isl1/
isl2a staining; data not shown).
Conversely, donor wild-type MNs form
functional axons (Figures 3C, 3D, and
3N; n = 7), eliciting muscle twitching,
in 30 hpf sfpq/ mutant embryos. The
donor neurons show some expected
late axonal deformation in the strongly
affected 3 dpf mutants (Figures 3E
and 3F).
SFPQ Regulates a Specialized Set
of Transcripts
To uncover the molecular complexity
driving loss of motility in sfpqkg41, we
analyzed the mutant transcriptome at
onset of the phenotype. Nimblegen mi-
croarray transcriptome analysis, on tripli-
cate samples of total RNA extracted from
50 sfpq/;Tg(mnx1:GFP) and sibling em-
bryos at the 22 ss, shows 571 of the
38,489 probes differentially expressed
(99% confidence level). The vast majority
of these transcripts (566/571) were down-
regulated in the homozygous sfpq mutant, and only five were
overexpressed (Figure 4A). Validation of the microarray data
was achieved by qPCR on randomly picked downregulated tran-
scripts (Figure 4B).
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ArrayStar analysis with the ZFIN gene annotation file provided
annotation with gene ontology (GO) terms for only 8% (3,043
probes) of the whole chip and 7% (41 probes) of the SFPQ differ-
entially expressed set (DES). With the customized gene annota-
tion file generated (see STAR Methods), 76% (29,364 probes) of
the chipwasmapped to gene identities and 70% (26,798 probes)
providedGO terms for the total set on the array. Of the DES, 81%
(461 of the 571 probes) weremapped to gene symbols (Table S1)
and 74% (424 probes) of these are associated with GO terms
(Table S2). Of the five upregulated in the DES, only three are
mapped to gene symbols. Out of the 26,798 total annotated
probes, a total of 16,745 whole chip were annotated with GO
terms. In total, 14 of the 59 GO terms at level 2 of the GO term
hierarchy were enriched in the annotated array (p < 0.05 after
multiple testing correction; Figure 4C). Considering all levels of
hierarchy, only 192 of the 8,624GO terms represented in the total
annotated array set were found enriched in the DES. These iden-
tified an unambiguously specific enrichment for molecules
involved in cell adhesion, cell junctions, neuronal/synaptic struc-
tures, glutamate, and Wnt signaling (Figure 4C; Table S2). More-
over, the three upregulated transcripts (pard3, arvcfb, and dgat1)
are involved in cell adhesion (Kausalya et al., 2004), cell polarity
(Shi et al., 2003), adherens junction complexes (Gladden et al.,
2010; Mariner et al., 2000), and dendritic spine morphogenesis
(Zhang and Macara, 2006). Finally, 21% of the SFPQ transcrip-
tome code for proteins identified as part of the synaptic prote-
ome. The mutants undergo a substantial downregulation of
neuronal-specific transcripts (genes listed in Figure S4) despite
an increase in neuronal populations (ectopic neurogenesis in
rhombomeric boundaries; Figure 1). Finally, when compared
with the whole-genome transcriptome, the differentially ex-
pressed set is substantially enriched for alternatively spliced
transcripts and transcripts containing multiple, longer than
average introns (Figure 4D; data not shown). The enrichment in
transcripts with long introns is reminiscent of the findings
showing a preference of TDP43 and FUS for binding to tran-
scripts with long first introns (Lagier-Tourenne et al., 2012).
Non-nuclear Localization of Splicing Factors and Introns
in Developing Neurons
Using antibodies, we assessed SFPQ protein localization in
wild-type and maternal proteins in the mutant. In line with the re-
ported role of SFPQ in many nuclear functions, we found robust
nuclear staining throughout zebrafish development,with system-
atic enhanced expression in nuclei of post-mitotic neurons
throughout development (Figures 5A and 5D–5F).Moreover, pro-
tein detection was unexpectedly found in variable levels in motor
axons (arrows in Figures 5B, 5D, and 5F) and discrete axonal and
dendritic populations throughout the CNS. Whole mount and
western blot show that no detectable SFPQ protein was found
in the mutant after the 12 ss (data not shown), showing that
maternal contribution stops by that stage.
In order to look at the dynamics of protein localization in live
zebrafish, we designed a functionally active GFP-tagged version
of zebrafish sfpq. Confirming the antibody results, we have found
that injection of z-SFPQ-GFP DNA leads to nuclear GFP expres-
sion, including bright nuclear foci, in all cell types andGFP detec-
tion in neurites of some neuronal populations, including MNs
(Figures 5E and 5F).
Together with the downregulation of neuronal and synaptic
transcripts in the sfpq/ zebrafishmutant, this supports the pos-
sibility of a non-nuclear function for SFPQ, related either to the
transport of mRNA and/or pre-RNA, or to non-nuclear RNA
processing events. To begin to discriminate between these
possibilities, we assessed whether SFPQ-regulated transcripts
were present in any unprocessed form in wild-type neurites.
We chose to screen for the first alternative intron of a series of
SFPQ-dependent neuronal transcripts. Introns were detected in
neurites of wild-type embryos for 11 of 36 neuronal transcripts
tested (Figures 5G–5M; Table S3; at least 20 embryos per probe),
but undetectable in homozygous sfpq mutants, suggesting that
unprocessed transcripts may be abundant in specific neuronal
populations and degraded, or not produced, in sfpq mutants.
The axonal presence of intronic sequences is coincidental
with detection of the core spliceosome protein snRNP70 (U1
snRNP), expressed in neurites across the whole of the CNS,
including motor axons (Figures 5N and 5O; n = 32).
Non-nuclear SFPQ Rescues the Motor Axon Defect of
the sfpq Mutant
To assess whether the presence of SFPQ in axons is functionally
relevant to MN function, we tested whether a cytoplasmic form
of the protein was able to rescue the neuronal defect in the
mutant. We made use of the human truncated protein lacking
the C-terminal non-canonical nuclear localization signal (NLS),
previously shown to prevent SFPQ nuclear import without
affecting the structure and functional domains (Dye and Patton,
2001). We found that injection of the RNA coding for this cyto-
plasmic form is able to restore both motor axon growth and
movement in the homozygous sfpq mutant (Figures 6E–6L;
Movie S3; n = 37 homozygous embryos). Deletion of a second
putative minor NLS sequence sitting in the coiled-coil domain
(see Figure 1E) affected the protein structure and function (Lee
et al., 2015; data not shown). The motor rescue can’t be
Figure 3. Sfpq Is Required Cell Autonomously for Motor Axon Development
Homotopic transplantation at 70%–80% epiboly of sfpq/; Tg(mnx1:GFP) and sibling Tg(mnx1:GFP) ventral spinal cord progenitors into wild-type or
sfpq/ hosts.
(A and B) Schematic of the transplants from donor (A) to host (B) embryo.
(C, D, and G–L) Lateral view, anterior to the left (C, D, and G–J) or transverse (K and L) of 30 hpf zebrafish transplanted trunks, showing the transplanted mnx1+
neurons in green and all axons in red (acetylated tubulin staining).
(E and F) Lateral view, anterior left of transplanted wild-type MNs (green) in early larvae (3 dpf) in wild-type (E) or sfpq/ (F) hosts.
(M) Quantification of VeLD interneurons in transplanted clones at 30 hpf (value is number of interneurons/total number of transplanted neurons, number of
embryos in box).
(N) Quantification of axonal lengths of transplanted neurons at 30 hpf. Scale bar, 100 mm.
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Figure 4. Sfpq Loss of Function Affects a Specific Set of Transcripts
(A) Scattered plot of the expression level of the total probe sets in the array. The 38,489 dots represent total individual probes for genes or expressed sequence
tags (ESTs). The gene expression level is expressed in relative arbitrary units of fluorescence intensity on a logarithmic scale. Genes whose expression level is
identical between the two groups lie on the diagonal line and the non-identical ones lie outside of the two lines parallel to the central diagonal purple line. The dots
positioned above the upper diagonal line represent probe sets that are upregulated and the dots appearing below represent probe sets that are downregulated in
the mutants as compared to siblings. Black dots represent those 571 probes with expression level at least 2-fold significantly different (p < 0.05, moderated t test)
between sfpq+/;+/+; (Tg:mnx1 gfp) and sfpq/;(Tg:mnx1 gfp) embryos. A high correlation (R2 = 0.98) was observed for the linear regression performed on the
gene set.
(B) Validation of microarray results by qRT-PCR performed on randomly picked downregulated transcripts. The gene expression data frommicroarray and qPCR
exhibited high correlation (Spearman’s rho test; r(6) = 1, p = 0.01). Statistical comparison was performed using paired t test with Bonferroni correction for multiple
(legend continued on next page)
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explained by residual nuclear localization of hsfpqDNLS, as
the threshold required for rescue by injection of the wild-type
form is well above detection level (Table S4) and mosaic co-in-
jection of pmnx1:GFP and pCS2:hsfpqDNLS DNA in the mutant
shows axonal expression of SFPQ in restored axons, with nuclei
lacking detectable hSFPQ protein (Figures 6E and 6F; n = 14;
Figure S3A).
The motor rescue obtained with the hsfpqDNLS is accompa-
nied by a strong morphological phenotype (short body axis
and variable cyclopia) likely induced by cytoplasmic accumula-
tion of SFPQ in the developing embryo. This phenotype is
observed in homozygous, but not in heterozygous and wild-
type siblings (Figures 6A–6D). The absence of phenotype in sib-
lings is explained by the presence of GFP-hsfpqDNLS in their
nuclei, due to correct transport elicited through complex with
endogenous SFPQ (inset in Figure 6D). Finally, qPCR done on
extracts from control and hsfpqDNLS-injected sfpq+/ progeny
for ten randomly picked neuronal SFPQ-dependent transcripts
shows rescue of expression level for six of these by the DNLS in-
jection (Figure 6M), demonstrating a substantial impact of the
cytoplasmic protein on transcript levels. The six transcripts
rescued are all connected to axonal and synaptic functions,
and we found intron retention for three of them (bcas3, nbeaa,
and tnr) in wild-type neurites. All together, these results show
that cytoplasmic SFPQ is sufficient to establish motor connecti-
vity and to protect key axonal transcripts from degradation.
Human SFPQ Mutations Found in ALS Patients Affect
SFPQ Localization and Induce Abnormal Motor Axon
Morphology
Exome sequencing of the human SFPQ gene (Refseq ID
NM_005066) in DNA samples from 151 index familial ALS (fALS)
patients revealed two independent sequential missense muta-
tions, N533H (c.1597A>C, we have called hsfpqN) and L534I
(c.1600C>A, we have called hsfpqL). These mutations affect adja-
cent residues within the second coiled-coiled domain of the mole-
cule (residues 528–555; Figure 7M) in a region fully conserved from
fish to mammals (Figure S3C). This coiled-coil domain has been
identifiedasbeing essential for the polymerization of SFPQdimers,
paraspeckle formation, and transcript processing (Lee et al., 2015).
From the ExAC database, we know that many missense variants
are found in normal individuals (Figure 7L). Bothmutations are pre-
sent in heterozygous form in the patients and are absent from all
public polymorphism databases (66,000 individuals), including
dbSNP142, 1000 Genomes (http://www.internationalgenome.
org/), the Exome Variant Server (http://evs.gs.washington.edu/
EVS/), and ExAC (http://exac.broadinstitute.org/). Unfortunately,
no familymemberswereavailable from thesekindreds for segrega-
tion analysis.
To evaluate the effect of humanmutations on the protein func-
tion, we tested whether a series of human variants was able to
rescue the zebrafish null mutant. We injected mRNA of wild-
type or variant alleles and characterized SFPQ protein localiza-
tion, axonal morphology, and larval motility. In addition to the
two ALS-linked mutations, we cloned five other missense vari-
ants, choosing those (fromALSDB and ExAC databases; Figures
S3B and S3C) that cover various areas of the gene, some only
found in normal individuals, others found in both ALS and normal
samples (Figure 7M). We quantified the degree of rescue after in-
jection of eight different human transcripts in replicated double-
blind experiments. We found that all SFPQ variants are able to
broadly rescue the mutant phenotype (including heart defects).
Larval motility is normal from its onset and MNs develop at the
same pace as wild-type (data not shown). However, when quan-
tifying axon length and shape, we find that the rescued motor
axons are often shorter and branch excessively in the hsfpqN
and L-injected mutant embryos (Figures 7A–7K, 7Q, and 7R),
but not in any injected with other missense variants. Correlated
to these defects, detection of SFPQ protein levels is severely
reduced in themotor axons of hsfpqN and L-injectedmutant em-
bryos and at normal levels in mutants rescued with wild-type and
the five other hsfpq variants (Figure 7P). Levels are rarely
reduced in the proximal axonal segment near the spinal exit
but are pronounced distally (Figures 7N–7O0), indicating that
ALS-linked mutations in the coiled-coil domain of the protein
may impair the axonal transport of SFPQ.
Altogether, our results show that axonal SFPQ is required for
normal motor axonal development, connectivity, and thereby
motility in zebrafish. Furthermore, two fALS-linked mutations,
lying within the coiled-coil domain of SFPQ, significantly impede
its distribution into the distal axon and affect motor axonal
branching in zebrafish, showing the importance of the coiled-
coil domain in axonal localization and normal motor axon devel-
opment. Perturbation of motor axon morphology in sfpq mutant
embryos rescued by fALS-linked variants may suggest a causal
link between these two mutations and the human motor degen-
erative disease. However, segregation data and additional cases
carrying mutations in the same residues are needed to support
this possibility further.
DISCUSSION
Our study shows that the ubiquitously expressed multi-func-
tional splicing factor SFPQ is functionally required for expression
of a restricted set of transcripts during development and carries
an essential non-nuclear function in developing motor axons.
Moreover, we identify two human sfpq point mutations affecting
the protein function in zebrafishMNs.We show that these human
mutated proteins are affected in their ability to localize in motor
axons and to elicit normal motor axon morphology in an endog-
enous SFPQ null background, while still enabling NMJ formation
and normal motility, indicating a likely role for axonal SFPQ in
comparisons. Fold change is expressed as the ratio between the linear expression levels of sfpq+/;/; (Tg: mnx1 gfp) and sfpq/;(Tg:mnx1 gfp) samples and
negative value represents downregulation of gene expression.
(C) GO analysis of the differentially expressed genes.
(D) Analysis of number of splice variants in whole transcriptome and SFPQ-dependent transcriptome. The SFPQ-dependent genes are substantially enriched for
high numbers of splice variants (one-sided Wilcoxon-Mann-Whitney rank-sum test with continuity correction, p = 2.51 3 1026).
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human motor function and a possible developmental origin to
some forms of motor degeneration.
SFPQ in RNA Transport and Cytoplasmic Processing
SFPQ has been previously described as associated with trans-
port granules in cell culture (Kanai et al., 2004) and very recently
shown to be required directly or indirectly for transport of RNA
regulon in sensory neurons (Cosker et al., 2016). Our study pro-
vides the first in vivo evidence that the cytoplasmic pool of SFPQ
is required for axon development through regulation of RNA
transport and/or processing in MNs. As transport granules are
indeed found to be essential for neuronal function (Kanai et al.,
2004), one possible requirement of SFPQ in axon may be trans-
port, as suggested by Cosker and colleagues in cultured sensory
Figure 5. SFPQ Protein Is Found in Axons, with Unprocessed RNA Targets and Spliceosome Component U1 snRNP70
Transverse single confocal sections of 24 hpf (A, N, andO) and 48 hpf (B–M) forebrain (A and I–K) or spinal cord dorsal to the top (G, H, L, andM) or to the left (B–D),
and lateral view of head, anterior to the left (E and F).
(A–F) SFPQ protein expression shown by antibody staining (A–D) or GFP-tagged ectopically expressed protein (E and F). Identity of red, green, and blue staining is
labeled on bottom right corner of each picture. Arrow shows axonal localization.
(G–K) Localization of first alternative introns (in red) of SFPQ-dependent transcripts, bcas3 (G and H), and gnao1a (I–K). Axons are stained by acetylated tubulin
antibody in green.
(L and M) High-resolution imaging of bcas3 intron detection (L; red) in motor axons stained with acetylated tubulin antibody (M; green).
(N and O) Double antibody staining of U1 snRNP70 proteins (N) with acetylated tubulin (O; merged channels) in spinal axons. Arrows are pointing to motor axons.
Scale bar, 25 mm.
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Figure 6. Non-nuclear Sfpq Rescues Loss of Transcripts and Axonal Phenotype in the coma Mutant
Lateral view of 30 hpf zebrafish (A–D) and spinal cord (G–L), anterior to the left.
(A–D) General morphology of sfpq/ (A); sfpq+/ siblings (B); sfpq/ injected with GFP-hsfpqDNLS (C) and sfpq+/ injected with GFP-hsfpqDNLS (D). Insets
showing localization of the human GFP-tagged protein in early ss embryos, CAAX-Cherry in red.
(legend continued on next page)
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neurons. However, we found that complete loss of SFPQ func-
tion, such as the one they induced in sensory neurons, severely
affects transcripts coding for transport proteins such as dynein
chains (Table S1), making it difficult to distinguish direct from in-
direct requirement in transport. More compelling is the ability of
our cytoplasmic version of SFPQ to rescue motor activity and
restore a subset of neuronal transcripts in the zebrafish mutant,
strongly demonstrating a cytoplasmic role in transcript mainte-
nance. One such function may be to protect transcripts (intron
retaining or not) from nonsense-mediated decay (Yap et al.,
2012). Intron retention has been previously reported in neurons
(Bell et al., 2010). Our study shows intron retention in developing
axons, and detection of U1 snRNP70 spliceosome protein,
opening a third possibility: SFPQ may be involved in some
form of extra-nuclear processing. Tissue-specific alternative
splicing has long been recognized as a powerful source of mo-
lecular diversity. This mechanism is particularly important in
the nervous system, where isoform variation is involved in syn-
apse formation, neurotransmission, synaptic plasticity, cell
recognition, and ion channel function (Grabowski and Black,
2001; Kiebler et al., 2013; Norris and Calarco, 2012). While
post-transcriptional regulation commonly occurs in the nucleus,
recent studies (Bell et al., 2010; Buckley et al., 2014; Glanzer
et al., 2005; Ko¨nig et al., 2007) indicate that modification of 30
UTR sequences, alternative polyadenylation, and even splicing
may be in some situation cytoplasmic, which opens the possibil-
ity of sophisticated local axonal and dendritic RNA processing
occurring within developing and mature neurons.
The possibility that a subset of transport granules may be
specialized for local processing of specific types of introns is a
very attractive idea in the context of neurons. Many of the
neuronal populations controlling our behaviors have the cell nu-
cleus tens of centimeters away from the site of active synapses.
The option of local splicing would be an advantageous mecha-
nism to generate alternative transcripts known to be required
for the rapid modulation of synaptic connectivity and other
neuronal functions. Our SFPQ mutants are ideal models to
now address these possibilities.
SFPQ and Neurodegenerative Disorders
SFPQ plays a key role in processing pre-mRNA coding for pro-
teins that are central to several neurodegenerative conditions.
It regulates tau pre-mRNA splicing by suppressing Tau exon
10 inclusion and thus regulating the balance of Tau4R/Tau3R ra-
tio (Ray et al., 2011), associated with tauopathies such as fronto-
temporal dementia (FTD; Cairns et al., 2007; Connell et al., 2001;
Grover et al., 1999; Hasegawa et al., 1998; Hasegawa et al.,
1999; Hutton et al., 1998; Mackenzie et al., 2010; Spillantini
et al., 1998). SFPQ is expressed at higher levels in the hippocam-
pus and cortex of human brain, the regions principally affected
by tauopathy (Ray et al., 2011). The nucleo-cytoplasmic redistri-
bution of SFPQ under pathological conditions is similar to that re-
ported for the RNA-binding proteins, TDP-43 and FUS, in ALS
and FTLD (Neumann et al., 2006; Urwin et al., 2010; Vance
et al., 2009). Microarray data analysis of transcripts in cortical
neurons of Alzheimer’s disease (AD) patients identified upregu-
latedSFPQ expression (Guttula et al., 2012). In addition to neuro-
degenerative diseases, SFPQ is also associated with other neu-
rodevelopmental disorders. Recent studies have associated
SFPQ and its partner NONO to autism spectrum disorders and
intellectual disability, and found SFPQ upregulated in the frontal
cortex of bipolar disorder patients (Nakatani et al., 2006; Le-Ni-
culescu et al., 2008).
Our work showed U1-snRNP70 and SFPQ together in motor
axons. Intriguingly, two very recent publications showed that
this U1 spliceosome protein functionally interacts with the
ALS-causative RNA processing protein FUS (Yu et al., 2015;
Sun et al., 2015). In these studies, the expectation is that these
interact inside the nucleus. However, we find partial co-localiza-
tion of SFPQwith FUS in axons and FUS has now been found en-
riched in synapses, suggesting that the synaptic dysfunction
observed in FUS mutant may be due to local axonal/synaptic
loss of function.
Our work puts a new light on these recent findings, shifting
the focus onto cytoplasmic interaction of these proteins and
RNAs in the normal context and potential dysregulation of
these interactions in neurodegenerative disorders. Neurode-
generation has mostly been understood as caused by seques-
tration of splicing factors and/or other proteins in cytoplasmic
aggregates that induce loss of essential protein function in
the nucleus and/or detrimental toxicity in the cytoplasm. How-
ever, our data support the intriguing possibility that some
neurodegenerative and neurodevelopmental disorders may
arise from progressive loss of a cytoplasmic RNA processing
function in axons and synapses, triggered during development.
Such a mechanism is suggested by a very recent study
showing that HNRNP2AB1 is shaping the splicing landscape
of neurons, a role specifically affected by ALS-associated mu-
tations in this gene (Martinez et al., 2016). Neuronal homeosta-
sis may be dependent upon a complex balance between nu-
clear and extra-nuclear RNA processing events controlled by
proteins such as SFPQ, HNRNPA2, U1 snRNP70, and FUS, a
balance that, when disturbed, may contribute mechanistically
to a wide range of neurological disorders.
(E) Whole-mount detection of SFPQ (red) in a 28 hpf sfpq/ mutant, injected at one-cell stage with pmnx1:GFP and pCS2:hsfpqDNLS DNA, expressing these
mosaically. Arrow shows motor axon. Note the negative nuclei (arrowhead).
(F) Measurement of ventral motor axon length in siblings and homozygous mutant uninjected or injected with RNA (DNLS) or DNA (MOSAIC DNLS) coding for
hSFPQDNLS. For the controls and RNA injections, the ventral motor axons were measured in five embryos over five-somite length upstream of the cloaca. For
mosaic DNA-injected sample, measures were done only in seven homozygous mutants, in the same trunk area for the rare SFPQ+ neurons.
(G–L) Lateral view, anterior to the left of spinal cords, showing rescue of the axonal defect both in the anterior (G and J) and posterior (H and K) trunk of sfpq/;Tg
(mnx1:GFP) by injection of the DNLS human SFPQ. Sibling axons are unaffected by the injection (I and L).
(M) qPCR results for six out of ten DES transcripts from 32 hpf siblings and sfpq/mutant embryos uninjected or injectedwith humanDNLS sfpqRNA. Bars show
expression fold changes compared to the expression level of the transcript in uninjected sibling embryos taken as reference. The four transcripts not plotted did
not show any improvement after DNLS rescue.
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Figure 7. Human Mutations Affect SFPQ Localization and Motor Development in the Zebrafish
(A–K) Lateral (A–F) and transverse (G–K, N, and O) views of the spinal cord in sfpq/mutant (A, B, and H), siblings (C and G), and homozygousmutant rescued by
wild-type human Sfpq (D and I) or L534 (E, J, and O) or N533 (F and K) mutant human Sfpq.
(L) Distribution of SFPQ variants in all exome-sequenced human individuals. In red, the position of the variants only found in fALS patients.
(M) Schematic of the wild-type hSFPQ protein and the seven variants cloned and tested in double-blind rescue experiments in the Tg(mnx1:GFP) background.
S8N (c.23G>A) is present in 4 SALS and 24 ExAC samples, showing amodest enrichment in SALS (p = 0.029, two-tailed Fisher’s test). P51L (c.152C>T) is private
to a single SALS patient and absent from all controls. M469V (c.1405A>G) is in a single SALS patient and twice in ExAC (p = 0.071). A515V (c.1544C>T) and A515T
(c.1543G>A) are in two and one ExAC normal individuals, respectively, and are located in the coiled-coil domain close to the two FALS variants we identified.
(N and O) Close-up of the motor axon and its environment, stained for SFPQ in red and GFP in green in the sfpq/; Tg(mnx1:GFP) rescued by injection of the
human (N and N0) or L-mutated form (O and O0). Arrowheads show localization of SFPQ in motor axons.
(P) Quantification of the a-SFPQ red fluorescent signal in motor axons on confocal stacks, for five pairs of motor axons per 48 hpf embryo stained with SFPQ
antibody. Measurement was done in no less than 30 (maximum, 46) embryos per variant injected. Injection is done in sfpq+/;Tg(mnx1:GFP) incross progeny. The
embryos showing poor signal intensity were genotyped and were all homozygous mutants.
(Q) Quantification of the length of ventral motor axons. Measures were made for five segments per 48 hpf embryo (five somites anterior to the cloaca) on confocal
stacks, using FIJI Single Neurite Tracer in no less than 28 (maximum, 41) embryos per variant injected. Injection is done in sfpq+/;Tg(mnx1:GFP) incross progeny.
The embryos showing shorter axon length were genotyped and were all homozygous mutants. Asterisks indicate highly significant reduction in axon lengths
compared to wild-type (pairwise ANOVA, ***p < 0.0001). The two significantly different variants show same difference when comparing pairwise to the other
variants. All other variants are not significantly different from wild-type.
(legend continued on next page)
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Zebrafish Embryos Maintenance
Zebrafish (Danio rerio) were maintained at 28C on a 14 hr light/10 hr dark cycle (Brand et al., 2002). Embryos collected were cultured
in fish water containing 0.003% 1-phenyl-2-thiouera to prevent pigmentation and 0.01% methylene blue to prevent fungal growth.
ENU mutagenesis was performed as previously described (Solnica-Krezel et al., 1994). The sfpq heterozygous mutant was
crossed with a set of GFP transgenic lines (Tg(isl1:GFP)rw0 (Higashijima et al., 2000), Tg(1.4dlx5a-dlx6a:gfp) (Ghanem et al.,
2003), Tg(TOP:gfp)w25(Dorsky et al., 2002), Tg(Bactin:HRAS-EGFP)vu119 (Cooper et al., 2005), Tg(Xla.Tubb2b:Hsa.MAPT-GFP))zc1
(Tilton and Tanguay, 2008) and Tg(mnx1:GFP)ml2/+(AB) (also known as Tg(HB9: gfp); Flanagan-Steet et al., 2005). Embryos
collected from incross of heterozygous mutant carriers from these transgenic mutant lines were selected for the transgene based
on GFP fluorescence.
The animal experimentations have been authorized by KCL Ethic Review Committee and under the HO license 70/7577.
Recruitment of Human Subjects
Patients were recruited from the Local ALS Clinic of Kings College London, Denmark Hill, UK and through neurogenetic clinics at
Concord Hospital, Sydney, Australia, under informedwritten consent. Patients were diagnosedwith definite or probable ALS accord-
ing to El Escorial criteria, and had a family history of ALS and/or FTD.
METHOD DETAILS
Genotyping of sfpq mutant
The homozygous mutant embryos were selected from offspring of incross of heterozygous carriers based on the brain and motility
phenotype at 28 hpf. Genomic DNA was separately extracted from 300 homozygous embryos and same number of siblings by stan-
dard protocol. The mutation was mapped by PCR amplification with random amplified polymorphic DNA (RAPD) and simple
sequence length polymorphism (SSLP) markers on a section of zebrafish chromosome 19. Linkage analysis and subsequent candi-
date gene approach indicated ‘sfpq’ as the gene mutated in the ENU mutant under study (Postlethwait et al., 1994).
Whole mount in situ hybridization and Immunohistochemistry
Whole-mount in situ hybridization was performed as described elsewhere (Thomas-Jinu and Houart, 2013). The following antisense
RNA probes were used: pax2.1 (Krauss et al., 1991), fgf8 (Reifers et al., 1998), foxb1.2 (Amoyel et al., 2005; Nakada et al., 2006),
EphA417, zash1a (Allende and Weinberg, 1994), rfng (Cheng et al., 2004), lhx5 (Toyama et al., 1995) and axin2 (Carl et al., 2007).
TUNEL (terminal deoxynucleotide (TdT) dUTP nick labeling) assay was performed using ApopTag peroxidase In situ Detection Kit
(Chemicon Cat# S7100) to identify apoptotic cells. Digoxigenin-labeled DNA fragments in the assay were detected by antibody con-
jugated to alkaline phosphatase (instead of anti digoxigenin-HRP recommended by manufacturer’s protocol) and color reaction was
carried out using NBT/BCIP.
Transgenic GFP embryos used for in situ hybridization with digoxigenin labeled antisense RNA probes were stained with Fast Red
(Roche) prior to GFP immunostaining. Immunostaining was carried out as previously described (Shanmugalingam et al., 2000). Pri-
mary antibodies and dilutions used were as follows: acetylated a-tubulin (Sigma, Mouse IgG2b, 1:1000), GFP (Amsbio, Rabbit IgG,
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1:500), F59 (mouse IgG1, 1:10), F310 (mouse IgG,1:10), phosho-Histone H3 (Millipore UK, Rabbit-IgG, 1:500), ZO-1 (Invitrogen,
mouse IgG1,1:500), HuC/D (1:200; Molecular Probes), Alexa Fluor 488 conjugated a-bungarotoxin (10 mg/ml PBS, 30min incubation,
Invitrogen), snRNP70 (1:100, AvivaSysBio), SFPQ (1:300, AbCam38148). At least 20 embryoswere used per experimental sample per
probe and per genotype. Images were acquired with a Nikon eclipse E800 microscope for in situ hybridization and confocal laser
scanning microscope (Nikon Eclipse 80i) for immunostaining and time lapse imaging. Images were adjusted for brightness and
contrast using Adobe Photoshop 8.0 and cell count and videos were processed using ImageJ software. Cell counts of proliferating
cells were performed by a person blind to the genotype of the embryos on Z stack image of WT and coma embryos. For statistical
analysis, two-tailed Student’s t test was performed using Microsoft Excel.
Live imaging
Time-lapse study was performed to investigate the mutant axonogenesis defects by live imaging a sfpq/; Tg(mnx1:GFP) embryos
from 20hpf until 72hpf. The primary motor axon initiates exit at 17hpf and reaches the target during the second day of embryonic
development in WT. Images were taken every 10 min for up to 2h at different stages of growth on a Nikon E80 confocal microscope.
The embryos were anesthetized in 0.02% tricaine, embedded in 1% low melting point agarose dissolved in E2 embryo medium in a
35 mm tissue culture plastic dish and filled with E3 medium for confocal imaging. The embryos were removed from the agarose after
imaging, maintained in E2 embryo media at 28C.
Rescue experiments and localization of GFP-tagged SFPQ proteins
The IMAGE clone (IMAGE: 6962536) of zebrafish sfpq complete cDNA sequence in pCMVsport6.1 (Source Bioscience) was
sequence verified and stored at –20C. The plasmid DNAwas linearizedwith FastDigest ClaI (ThermoScientific) and used as template
for in vitro synthesis of capped sfpq mRNA using the mMessage Sp6 kit (Ambion). The mutant rescue was performed by injecting
z-sfpq mRNA into one-cell stage embryos derived from the sfpq/;Tg(mnx1:GFP) incross and sfpq/;Tg(isl1:GFP) incross.
The extent of the rescue was determined by assessing the brain phenotype, motility and the motor neuron expression at 36hpf. A
minimum of 180 pg/embryo is required for full phenotypic rescue.
The Gateway cloning system (Invitrogen, Carlsbad, CA) and Tol2 kit (Kwan et al., 2007) was used to clone the full-length zsfpq
cDNA to generate the expression constructs UAS-zSFPQ-GFP and Hs-zSFPQ-GFP. The GFP tagged human constructs, containing
full length GFP-PSF and theGFP-PSFD 1-702 (Dye and Patton, 2001), obtained fromProf. James Patton were subcloned into pCS2+
for in vitro transcription of wild-type hsfpq and DNLShsfpq. The human SFPQ L534I and N533H mutant forms were made by site
directed mutagenesis according to the manufacturer’s protocol (Quickchange II Site-Directed Mutagenesis Kit, Stratagene) using
a Gateway pDONR221 entry clone containing WT full length coding SFPQ (Gateway, Invitrogen). These were then subcloned in
pcDNA3.1 NT-GFP using the TOPO TA Expression Kit (Invitrogen K4810-01), by PCR amplification from pDonr221 with the primers
sfpqORF50: ATGTCTCGGGATCGGTTCCGG and sfpqORF30: CTAAAATCGGGGTTTTTTGTTTGG and the Q5 High-Fidelity proof-
reading DNA Polymerase (NEB M0491S).
Mutation screening of Human SFPQ
Exome sequencing was performed on 151 index cases from the UK (n = 87) and Australia (n = 64), with an average age-of-onset of 59
years and an average disease duration of 34 months. UK FALS cases were all Caucasian individuals from the South -East of London
and Kent. FALS cases from Australia were predominantly of European ancestry. All samples were free from currently known ALS-
associated coding mutations and the intronic C9orf72 GGGGCC repeat expansion. Samples were captured using either Nimblegen
V3, Illumina TruSeq Exome Enrichment or Agilent SureSelectXT Human All Exon-V5-UTR probes and 100bp paired-end reads
sequenced on an Illumina HiSeq-2000. Readswere assembled to the hg19 reference genome achieving an average of 115x coverage
across all Refseq coding bases, and variants were called with ‘SAMtools Mpileup’. Novel SFPQ variants which were absent from all
public variant databases were confirmed by PCR from original stock DNA and directly sequenced using Big-Dye Terminator v1.1
chemistry and an ABI3130 genetic analyzer (Applied Biosystems Pty Ltd, Warrington, UK). Sequence chromatograms were analyzed
for mutations using Sequencher 4.10 (Gene Codes Corporation, Ann Arbor, Michigan, USA).
Spinal motor axon mosaic experiment
Progenies from incrosses of sfpq+/;Tg(mnx1:mGFP) were injected with CAAX-mcherry RNA at one cell stage (donor embryos).
Mosaic embryos were produced by homotopic and homochronic transplantation into wild-type hosts. Around 20 dorso-posterior
epiblast cells collected from late gastrula stage donor embryo (80%–100% epiboly; collected by capillary suction around the pos-
terior midline) were placed at the equivalent location in the same stagewild-type host embryo. The donor and host embryowere iden-
tified as sfpq/ orWT sibling based on theMHB and axonogenesis phenotype at 24hpf and identity confirmed by PCR at 36hpf after
clonal analysis. Embryos with the transplants that led to the incorporation of the donor cells (mcherry+) in the ventral spinal cord and
GFP-positive motor axons were selected for further analysis. Only 25% of the donor clones are homozygous for sfpq. We trans-
planted more than 120 embryos across different days. To assess the behavior of wild-type neurons in mutants, the same approach
was taken with Tg(mnx1:mGFP) wild-type donors into host embryos from sfpq+/ crosses.
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DNA Microarray
A total of six set of embryos (three pools of 50 homozygous sfpq;Tg(mnx1:GFP) and WT sibling embryos) were fast-frozen in liquid
nitrogen and stored at – 80C until RNA extraction. All homozygous sfpq embryos exhibits impaired motility at 22hpf and this feature
was used to segregate mutant embryos from WT siblings for the study. Total RNA was isolated using high pure RNA isolation kit
(Roche). Quality and purity was assessed by Nanodrop absorbance ratios and by Agilent Bioanalyzer (BRC genomics core facility,
KCL) and used for microarray analysis and subsequent quantitative RT-PCR experiments.
Six RNA pools of 10 mg of total RNA each were used to make double stranded cDNAs, synthesized using the SuperScript Double-
Stranded cDNA Synthesis Kit (Invitrogen). These were hybridized separately on NimbleGen 12 3 135 k zebrafish gene-expression
arrays. The array contains 38,489 probe sets with up to 3 probes of 60-mer oligonucleotides per gene. The arrays represented at
least 24,000 genes plus additional ESTs from multiple zebrafish tissues. The design of the array relied on gene and EST information
from several sources; Ensembl 46 (August 2007, Zv7), RefSeq (September 2007), TIGR (Release 14.0), UniGene (Build 54), Vega 27,
and ZGC (August 2007).
RT-qPCR
Total RNA was extracted from pools of sfpq/;Tg(mnx1:GFP) and sfpq+/; +/+;Tg(mnx1:GFP) embryos at 24hpf using TRIZOL RNA
isolation reagent (Invitrogen). cDNA was synthesized (First strand CDNA synthesis kit, GE Healthcare) after treating the RNA isolated
with DNaseI (Ambion TURBO DNase Free kit). Products were purified using Qiaquick PCR purification kit (QIAGEN). Reactions were
performed using SYBR Green I Master kit (Roche) on a Stratagene MX3005P and data analyzed using MxPro software. Three inde-
pendent biological replicates of the WT sibling and mutant pools were included in the analysis and all reactions were carried out in
triplicates. Cycling parameters were as follows, 95C 10 min for 1 cycle then 95C 30 s, 60C 30 s, 72C 30 s for 40 cycles then 95C
60 s, 60C 30 s, 95C 30 s for all primer sets. Primer sequences used are as follows: bcas3 (F – 50 GCATGTGGAGATAATGCCCA 30,
R – 50 CAGTCCTTCGCCATCAGAAT 30); fstlb (F – 50 TTCCTCAACTGCCTGAAACC 30, R - 50 TTCCTCAACTGCCTGAAACC 30);
dlg1 (F – 50 TTGGCTGTGAATGCTGTTTG 30, R – 50 GGCTCCCTTGTGATCTCATC 30); crim1 (F – 50 CCACACTGTCCAGATGATCC
30, R – 50 CTCGTCCATGTACGTCTTCC 30); nbeaa (F – 50 GGTGATAACGGTGTTGTGGA 30, R – 50 CCCTGAACTGAGAGGAAACG
30); tnr (F – 50 GGCTCAGTCAACACAGGAAT 30, R - 50 TCTCTTGGCTTCCTCTCACT 30); smyd3 (F – 50 AAACTGCCTGTCAAAGTTGC
30, R – 50 TCCGTCTTCTCCTCACTCAT 30); gpc3 (F – 50 GCAAAATGGAGGAGCGTTAC 30, R – 50 GCATCAGAGCCCAGAATGTA 30);
edil3 (F – 50 CCAGCAGATAACAGCCTCAT 30, R – 50 TCTTTCCGTCATCGCTGTAG 30) and ef1a (F – 5 TTGAGAAGAAAA
TCGGTGGTGCTG 30, R – 50 GGAACGGTGTGATTGAGGGAAATTC 30). The expression levels of the genes selected were normalized
to an endogenous control gene ef1a.
Intronic whole mount in situ hybridization
Antisense probes against the sequences of intron 2 of the following twenty genes (ncam1b, igsf21a, nbeaa, gria3b, Hpca, gnao1a,
cadm4, ank2b, gng7, cacng2a, oprl1, lrp1bb, bcas3, grip2b, TLN2, rbms3, fut8, Chrm3a, dbn1, ctnna2) were made from PCR ampli-
fied fragments (50 primers containing the sp6 promotor sequence) using zebrafish genomic DNA as template. RNA probes of the
genes were then made using the standard protocols. Whole mount in situ hybridization for the intronic genes were performed on
24h and 48h embryos using an InSituPro automated system (Intavis, Germany).
QUANTIFICATION AND STATISTICAL ANALYSIS
Gene Expression and Ontology Analysis
The gene expression level and folds changes calculated from six separate samples were normalized by quantile normalization
and the gene expression values were generated by RMA (Robust Multichip Average) algorithm. The processed microarray data
files received from the Nimblegen were subsequently analyzed using ArrayStar4 software (DNASTAR, Inc. Madison, USA).
Technical replicates were all highly correlated (R2 > 0.97 on all replicate pairs; cross R2 test) and the replicate sets were created
for sfpq/;Tg(mnx1:GFP) and sfpq+/; +/+;Tg(mnx1:GFP) by mean method for subsequent gene expression analyses. The scattered
plot of the gene expression levels showed a high linear correlation (R2 = 0.98) between the two groups. Geneswere considered differ-
entially expressed when the level of expression change was at least two fold (upregulation or downregulation) in the homozygous
sfpq embryos as compared to its WT siblings and the difference between the two groups was significant (p < 0.01 moderated
t test, in which the false discovery rate (FDR) was controlled by the Benjamini Hochberg correction method).
Ontology analysis conducted for the biological interpretation of the differentially expressed genes using ZFIN gene annotation file
gave only few annotations as themicroarray design is based on ZV7 release. Hencemore recent gene annotations were downloaded
from ZFIN (release 9, April 24th 2013), and the probe sequences were aligned against the D.rerio genome from ENSEMBL release 71.
The GO terms and hierarchy was downloaded from Gene Ontology (http://www.geneontology.org) on May 7th 2013. All genes and
functional annotations were imported in ArrayStar4 for further analysis, TheGO termswith p < 0.05 (after Benjamini Hochberg correc-
tion) and with percentage of genes per GO term above the percentage of the genes of its major/ first level GO classification is consid-
ered as enriched among the differentially expressed genes.
The number of variant transcripts per gene was obtained using the genome provided by ENSEMBL release 75 (Zfin v9, February
2014) (Allende and Weinberg, 1994). The plots and computations were done using R version 3.1.0 (http://www.R-project.org/).
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Validation of microarray results
Validation of microarray results by qRT-PCR was performed on six randomly picked transcripts downregulated according to tran-
scriptome analysis. The correlation of the gene expression data from microarray and qPCR was tested using Spearman’s Rho
test. Statistical comparison was performed using paired t test with Bonferroni correction for multiple comparisons.
Splice variant analysis
Analysis of number of splice variants in whole transcriptome and DES transcriptome was performed using one-sided Wilcoxon-
Mann-Whitney rank sum test with continuity correction based on the number of transcripts for each gene.
Quantification of neuronal morphological parameters
Quantification of the aSFPQ fluorescent signal in motor axons was done in double-blind on confocal stacks, for 5 pairs of motor
axons per embryo using FiJi. Measurement was done in no less than 30 (max. 46) embryos per variant injected. Quantification of
ventral motor axon lengths and branching complexity weremade for 5 segments per embryo (always 5 somites anterior to the cloaca)
on confocal stacks, using FIJI Single Neurite Tracer in no less than 28 (max. 41) embryos per variant injected. The variants signifi-
cantly different from wild-type show same difference when comparing pairwise to the other variants (pairwise ANOVA, p < 0.0001
and p < 0.001 respectively).
DATA AND SOFTWARE AVAILABILITY
The accession number for the microarray datasets reported in this paper is ArrayExpress: E-MTAB-5559.
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